Remedy Pharmaceuticals Receives Significant Patent Allowance for CIRARA in Stroke Treatment Remedy Pharmaceuticals has gained significant patent permits for CIRARA, enhancing treatment options for large hemispheric infarctions and wake-up strokes.

Remedy Pharmaceuticals Receives Significant Patent Allowance for CIRARA in Stroke Treatment #United_States #New_York #Stroke_Treatment #Remedy_Pharmaceuticals #CIRARA

Remedy Pharmaceuticals Reveals Breakthrough Stroke Treatment Data at International Stroke Conference 2025 At the ISC 2025, Remedy Pharmaceuticals shared promising data from studies on CIRARA, showing marked improvements in stroke recovery outcomes.

Remedy Pharmaceuticals Reveals Breakthrough Stroke Treatment Data at International Stroke Conference 2025 #USA #New_York #Stroke_Treatment #Remedy_Pharmaceuticals #CIRARA

Remedy Pharmaceuticals to Present Efficacy Data for CIRARA at 2025 International Stroke Conference Remedy Pharmaceuticals will unveil compelling data on CIRARA at the ISC 2025, showcasing its potential for improving outcomes in Large Hemispheric Infarction patients.

Remedy Pharmaceuticals to Present Efficacy Data for CIRARA at 2025 International Stroke Conference #United_States #Los_Angeles #Stroke_Treatment #Remedy_Pharmaceuticals #CIRARA